Pairing cancer treatments shows patient improvement

September 6, 2013 by Paul Mayne
Western Oncology professor Dr. Barbara Fisher’s preliminary research data shows combining radiation with a standard chemotherapy drug for patients with a brain tumour can increase three-year survival rates by 35 per cent. Credit: Paul Mayne, Western News

Combining two common brain tumour treatments could lead to greater results, according to preliminary data from Western Oncology professor Dr. Barbara Fisher.

The Lawson Health Research Institute scientist showed combining radiation with a standard chemotherapy drug for patients with low-grade gliomas can increase three-year by 35 per cent.

Low-grade gliomas, tumours that start in the brain, affect 10-15 per cent of the entire population of brain cancer patients and have only a 50 per cent three-year survival rate with surgery and/or radiation alone. These low-grade gliomas have high-risk features, which can behave aggressively and pose the threat of becoming malignant

In her study, Fisher and her team administered Temozolomide to 136 patients with low-grade gliomas during , and then one week per month for the next year. Following a period of observation, the results were compared to an existing database of patients treated only with radiation.

The preliminary results showed the combined increased the three-year survival rates by over a year.

"My hope is that the treatment will prolong survival rates, and that some of these patients can live several years longer with a higher quality of life," said Fisher, also a Radiation Oncologist at London Health Sciences Centre (LHSC).

While this is great news, it should not be seen as a 'cookie-cutter' method for treating other forms of cancer.

"Every cancer is completely different," Fisher said. "The fact that something works, in say melanoma, doesn't mean it's going to work in lung cancer. Every tumour is different, sometimes there are bigger leaps in one area and not another.

"I don't see that it's going to be generally used outside brain tumours. The way goes everyone wants that giant step, but it's the series of little steps on top of each other that makes the difference, and that is how treatment has improved significantly since I started."

Fisher's results were recently reported at the American Society of Clinical Oncology meeting. Despite the positive outcomes, there is still a great deal to be learned about the exact mechanism Temozolomide activates when combined with radiation.

"Does it interact with the radiation to make it more affective, or is it a separate mechanism that works differently?," said Fisher, who will continue to explore this interaction with her colleagues, including LHSC's Dr. David MacDonald, a collaborator on this study.

"When you find something that works, it sort of opens the door and you can start adding to that, or asking why did it work and who did it work for. It's what keeps you coming into work," Fisher said.

Explore further: Fasting makes brain tumors more vulnerable to radiation therapy

Related Stories

Fasting makes brain tumors more vulnerable to radiation therapy

September 11, 2012
A new study from USC researchers is the first to show that controlled fasting improves the effectiveness of radiation therapy in cancer treatments, extending life expectancy in mice with aggressive brain tumors.

Chemo, radiation followed by surgery improves survival in lung cancer patients

April 30, 2013
In one of the largest observational studies of its kind, researchers report that a combination of chemotherapy and radiation followed by surgery in patients with stage 3 non-small cell lung cancer improves survival.

First direct evidence of HPV-related tonsillar cancer on the rise in Canada

August 13, 2013
American and European research shows an alarming increase in the rate of tonsillar cancer related to the human papilloma virus (HPV), a sexually transmitted virus. Experts suggest a similar trend has emerged in Canada, but ...

New drug enhances radiation treatment for brain cancer in preclinical studies

May 14, 2013
A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma ...

Surgery and radiation improve survival for metastatic gastric cancer patients, study shows

February 27, 2013
Researchers at Moffitt Cancer Center studied patients with metastatic gastric cancer and found that those who have both surgery and radiation have better survival than those who receive one or no form of treatment.

Cancer pain could be reduced with fewer radiation treatments

June 4, 2013
New results from the NCIC Clinical Trials Group (CTG) at Queen's University have shown that fewer radiation treatments can help relieve pain caused by the spread of cancer to bones. Specifically, the research shows patients ...

Recommended for you

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.